SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-16-016808
Filing Date
2016-11-18
Accepted
2016-11-17 21:34:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2230313z424b5.htm 424B5 390590
2 G643877.JPG g643877.jpg GRAPHIC 10723
3 G998644.JPG g998644.jpg GRAPHIC 15955
  Complete submission text file 0001047469-16-016808.txt   428563
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214384 | Film No.: 162006376
SIC: 2834 Pharmaceutical Preparations